Expresscells

Revenue-Generating CRISPR Company

Follow Expresscells to be notified if they later decide to raise funding.

Highlights

1
In market and generating revenue through a growing list of customers with repeat business
2
Patented technology: we handle difficult genetic engineering projects faster than competitors
3
Similar companies have been acquired at attractive multiples

Our Team

Our scientific founder, Oscar Perez-Leal, was frustrated with older gene-editing technologies. They take too long and can't handle complicated projects. Rather than grumble, he developed a better way, now called FAST-HDR. The good news? There are hundreds of thousands of scientists like Oscar in the world. We want to work with all of them.

Pitch

Overview